NCT05230082

Acupuncture in Myasthenia Gravis (AcuMG)

Acupuncture Treatment for Individuals With Myasthenia Gravis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: HealthPartners Institute · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to determine the effect acupuncture treatment on individuals with a diagnosis of Myasthenia Gravis (MG). A total of 20 people with MG will be enrolled in this study to receive acupuncture treatment 2 times a week for 12 weeks. Participants will be randomized into two groups: 1) Immediate start and 2) Delayed start (12 weeks). The delayed start group will act as a control group for the first 12 weeks, but then receive acupuncture treatment for 12 weeks. It is hypothesized that patients with MG who receive acupuncture treatment will have improved quality of life and activities of daily living compared to no treatment.

Conditions

• Myasthenia Gravis

Interventions

Type	Name	Description
OTHER	Acupuncture	Acupuncture treatments will be separated by a minimum of two days and a maximum of 14 days. Treatment sessions will be identical for both groups. Standard, sterile stainless-steel, disposable needles will be inserted at acupuncture points with a total of 18 needles for each treatment session. The depth of the needle will be approximately 10-20 millimeters. Needles will be left in place for 30 minutes.

Timeline

• Start date: 2022-05-25
• Primary completion: 2024-04-30
• Completion: 2024-04-30
• First posted: 2022-02-08
• Last updated: 2025-09-18
• Results posted: 2025-09-18

Locations

1 site across 1 country: United States